| RS886039269 |
DEPDC5
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS886039270 |
DEPDC5
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, familial focal |
| RS886039273 |
DEPDC5
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS886039282 |
KIF7
|
Health Risk |
Pathogenic |
Multiple epiphyseal dysplasia, Al-Gazali type |
| RS886039296 |
ABCA12
|
Health Risk |
Likely pathogenic |
— |
| RS886039297 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS886039299 |
ABCA4
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS886039300 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Cone dystrophy |
| RS886039302 |
ACTA1
|
Health Risk |
Likely pathogenic |
— |
| RS886039303 |
ACTA2
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 6 |
| RS886039304 |
ALDH3A2
|
Health Risk |
Pathogenic |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS886039305 |
ALDH3A2
|
Health Risk |
Pathogenic |
— |
| RS886039306 |
ALG11
|
Health Risk |
Likely pathogenic |
— |
| RS886039307 |
ALOX12B
|
Health Risk |
Pathogenic |
— |
| RS886039308 |
ARX
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS886039310 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS886039311 |
BEST1
|
Health Risk |
Likely pathogenic |
Vitelliform macular dystrophy 2, Retinal dystrophy |
| RS886039312 |
BRAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal-onset encephalopathy with rigidity and seizures, Neurodevelopmental disorder with cerebellar atrophy and with or without seizures |
| RS886039313 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS886039314 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS886039315 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS886039316 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS886039318 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS886039319 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS886039320 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS886039321 |
BTK
|
Health Risk |
Likely pathogenic |
— |
| RS886039323 |
CACNA1E
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 69 |
| RS886039324 |
CACNA1G
|
Health Risk |
Likely pathogenic |
— |
| RS886039325 |
CAV3
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome |
| RS886039326 |
CD40LG
|
Health Risk |
Likely pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS886039327 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS886039328 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS886039329 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS886039330 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Epidermolysis bullosa dystrophica, 7 conditions |
| RS886039331 |
CREBBP
|
Health Risk |
Pathogenic |
— |
| RS886039332 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Abnormal lung growth |
| RS886039333 |
CYBB
|
Health Risk |
Pathogenic |
— |
| RS886039334 |
CYBB
|
Health Risk |
Pathogenic |
— |
| RS886039335 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS886039336 |
CYBB
|
Health Risk |
Pathogenic |
— |
| RS886039337 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS886039338 |
CYBB
|
Health Risk |
Pathogenic |
— |
| RS886039339 |
DCX
|
Health Risk |
Pathogenic |
— |
| RS886039340 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, DNAH11-related disorder |
| RS886039341 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 7, Primary ciliary dyskinesia |
| RS886039343 |
DSP
|
Health Risk |
Pathogenic/Likely pathogenic |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS886039344 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS886039345 |
EBP
|
Health Risk |
Pathogenic/Likely pathogenic |
MEND syndrome, MEND syndrome |
| RS886039346 |
EEF1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 33 |
| RS886039347 |
EDA
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, See cases |
| RS886039348 |
EDAR
|
Health Risk |
Pathogenic/Likely pathogenic |
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type |
| RS886039349 |
EFTUD2
|
Health Risk |
Pathogenic |
Hereditary syndromic Pierre Robin syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS886039351 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Cutis laxa |
| RS886039352 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Exostoses |
| RS886039353 |
EXT1
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS886039354 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS886039355 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Chondrosarcoma |
| RS886039356 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Exostoses |
| RS886039357 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS886039358 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS886039359 |
FAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Thyroid cancer, nonmedullary |
| RS886039360 |
FBN1
|
Health Risk |
Pathogenic |
— |
| RS886039361 |
FGD4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS886039362 |
FH
|
Health Risk |
Likely pathogenic |
Fumarase deficiency, Hereditary cancer-predisposing syndrome |
| RS886039363 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS886039364 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Fumarase deficiency |
| RS886039365 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS886039366 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS886039367 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Fumarase deficiency |
| RS886039368 |
FH
|
Health Risk |
Pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary cancer-predisposing syndrome |
| RS886039369 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS886039370 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS886039371 |
FLCN
|
Health Risk |
Pathogenic |
Colorectal cancer, Nonpapillary renal cell carcinoma |
| RS886039372 |
FZD4
|
Health Risk |
Likely pathogenic |
— |
| RS886039373 |
GABRA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 19 |
| RS886039374 |
GABRB2
|
Health Risk |
Pathogenic |
— |
| RS886039375 |
GABRB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy 92, Developmental and epileptic encephalopathy 92 |
| RS886039376 |
GALNS
|
Health Risk |
Likely pathogenic |
— |
| RS886039377 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS886039378 |
GCH1
|
Health Risk |
Likely pathogenic |
— |
| RS886039379 |
GCH1
|
Health Risk |
Pathogenic |
Dystonia 5, GTP cyclohydrolase I deficiency |
| RS886039380 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 2, Monogenic diabetes |
| RS886039382 |
GMPPB
|
Health Risk |
Pathogenic |
— |
| RS886039383 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS886039384 |
GPC3
|
Health Risk |
Pathogenic |
— |
| RS886039385 |
KCNH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome, Cardiovascular phenotype |
| RS886039386 |
HNF1A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS886039387 |
CXorf65;IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS886039388 |
IRF6
|
Health Risk |
Pathogenic |
Orofacial cleft 6, susceptibility to |
| RS886039389 |
IRF6
|
Health Risk |
Pathogenic |
— |
| RS886039390 |
IRF6
|
Health Risk |
Pathogenic |
— |
| RS886039391 |
IRF6
|
Health Risk |
Pathogenic/Likely pathogenic |
Orofacial cleft 6, susceptibility to |
| RS886039392 |
ITPR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Spinocerebellar ataxia type 29 |
| RS886039393 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Deafness |
| RS886039394 |
JAK3
|
Health Risk |
Pathogenic/Likely pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, Severe combined immunodeficiency disease |
| RS886039395 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Martsolf syndrome 1 |
| RS886039396 |
KCNB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS886039397 |
KCNT1
|
Health Risk |
Pathogenic |
— |
| RS886039398 |
KDM6A
|
Health Risk |
Pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS886039399 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |